Specificity: Can the Method Tell Your Peptide From Everything Next to It?

A chromatogram shows a peak at the expected retention time. The natural reading is that the peak is your peptide. The accurate reading is that something eluted at that time. Everything that distinguishes those two statements is the validation characteristic called specificity, and it is the one most often taken on trust.

Quick answer

What is specificity? ICH Q2(R2), the international guideline on validation of analytical procedures adopted on 1 November 2023, defines specificity as describing the ultimate state, measuring unequivocally a desired analyte, while selectivity is a relative term describing the extent to which particular analytes in mixtures or matrices can be measured without interferences from other components with similar behaviour. In practice it answers one question: could anything else in the vial have produced this result?

The guideline gives three routes to demonstrating it, and a research buyer reading a certificate is entitled to know which one was taken.

The three routes

The third route is why a mass spectrum carries identity weight that a retention time does not, a distinction covered in HPLC versus mass spectrometry. The guideline notes that where the technology ensures specificity, additional experimental studies may not be required, if justified.

The requirement people forget: negative results

For identification tests, ICH Q2(R2) asks for something that rarely appears in discussions of purity. The capability to identify an analyte is confirmed by obtaining positive results comparable to a reference material using samples containing the analyte, along with negative results from samples which do not contain the analyte. The guideline goes further: the identification test should be applied to materials structurally similar to or closely related to the analyte, to confirm that a positive result is not obtained.

That second half is the whole test. A method that says yes to your peptide is useless if it also says yes to a deletion sequence missing one residue. For peptides this is not a theoretical worry — deletion and truncation sequences are the characteristic impurities of solid-phase synthesis, described in peptide impurities, and they are structurally similar to the target by construction.

What specificity means for a chromatogram

For separation techniques, the guideline is concrete: suitable discrimination should be investigated at an appropriate level, and for critical separations in chromatography, specificity can be demonstrated by the resolution of the two components which elute closest to each other.

Not the resolution of the main peak from the solvent front. The resolution of the two closest peaks — the hardest pair in the run. A method that separates everything except the one pair that matters has not demonstrated specificity, however clean the chromatogram looks. How to read what is actually in front of you is covered in reading an HPLC chromatogram.

A documented case of a method that could not see

The clearest illustration in the recent literature is not a research-grade certificate but an official compendial method. A 2022 study examined the European Pharmacopoeia thin-layer chromatography method for detecting residual HEPES buffer in gallium-68 radiopharmaceuticals. In the samples assessed, HEPES could not be detected by that method within four minutes of incubation in an iodine-saturated chamber. The authors developed a replacement HPLC procedure which was linear between 3 and 100 µg/mL with a correlation coefficient of 0.999 and a quantitation limit of 3 µg/mL, and concluded that the compendial TLC method may not be sufficiently sensitive and thus unsuitable for quality control release.

The substance was present. The method returned nothing. That is the gap between not detected and not there, examined from the other side in what not detected actually means.

Stability-indicating: specificity against things that do not exist yet

A method used to judge whether material has survived storage has a harder job. It must separate the peptide not only from the impurities present today but from the degradation products that will appear later. The guideline's approach is to create them deliberately: samples containing appropriate amounts of impurities can be generated through deliberate stressing of product materials.

A 2022 validation of a method for the therapeutic peptide teduglutide did exactly this, performing forced degradation studies under thermal stress at 40 °C and 60 °C, mechanical shaking and accelerated light exposure, and confirming the procedure could detect and characterise the resulting degradation and modification products. A 2024 study developing a gradient reversed-phase method for a synthetic decapeptide separated six related impurities and ran a stress study for the same reason.

The degradation routes those studies are provoking — oxidation, deamidation, aggregation — are the ones described in peptide degradation.

When one method is not enough

ICH Q2(R2) is explicit that a single procedure may not suffice: where one analytical procedure does not provide sufficient discrimination, a combination of two or more procedures is recommended to achieve the necessary specificity or selectivity. Its own example is a titration used to assay a drug substance, where the combination of the assay and a suitable test for impurities may be used.

This is the structural argument for why a certificate carrying both a chromatographic purity figure and a mass confirmation says more than either alone — and why neither, by itself, establishes both identity and content.

What to ask, and what to conclude

• Ask which measurement principle produced the identity claim. Retention time is a comparison; exact mass is a property of the molecule.
• Treat a single chromatographic peak as a quantity, not an identity. It is the share of detected material eluting at one time — see what 99% purity actually means.
• Ask whether the method is stability-indicating if you intend to use it to judge stored material. If no forced degradation was run, it has not been shown to detect degradation.
• Do not read a clean chromatogram as an absence of impurities. It may equally be a method that cannot resolve them, or cannot see them at all.
• Where two orthogonal methods agree, believe the agreement more than either number. That is the guideline's own second route, and it is the cheapest confidence available.

Key takeaways

• ICH Q2(R2) distinguishes specificity (measuring unequivocally a desired analyte) from selectivity (measuring without interference from components with similar behaviour).
• Three routes establish it: absence of interference, orthogonal procedure comparison with a different measurement principle, and technology-inherent justification.
• Identification tests require negative results on structurally similar materials, not only positive results on the analyte.
• For chromatography, specificity is demonstrated by resolving the two closest-eluting components — the hardest pair, not the easiest.
• A published European Pharmacopoeia TLC method failed to detect HEPES at all; a replacement HPLC method quantified it down to 3 µg/mL.
• Stability-indicating methods are proved by deliberately stressing material — thermal, mechanical and light stress in one published peptide example.
• Where one procedure cannot discriminate, the guideline recommends combining two or more.

Frequently asked questions

Does a research-grade certificate state specificity?

Almost never, and it is not expected to. The practical substitute is knowing which methods produced which claims, so you can judge what each one could and could not have distinguished.

Is a mass spectrum automatically specific?

It is the strongest single piece of identity evidence commonly available, and the guideline recognises isotope resolution as technology-inherent justification. It still will not distinguish between isomers of identical mass — which is why racemisation has its own test, described in racemisation and D-amino acids.

What is an orthogonal method?

One applying a different measurement principle, not merely a different instrument. Two HPLC runs on different columns are not orthogonal in the sense the guideline means; chromatography compared against NMR or mass spectrometry is.

Why does resolution of the closest pair matter so much?

Because an unresolved pair is counted as one peak, and a co-eluting impurity is silently added to the purity figure for the target. The number goes up, not down, which is why it is not self-announcing.

Does this change what I should buy?

It changes what you conclude from the paperwork. A certificate establishes what the supplier's methods could see. Where you need more confidence, a second measurement by a different principle is worth more than a second certificate by the same one.

Sources

• International Council for Harmonisation. ICH Harmonised Guideline Q2(R2): Validation of Analytical Procedures. Final version adopted 1 November 2023. ICH guideline
• Migliari S, Scarlattei M, Baldari G, Silva C, Ruffini L. A specific HPLC method to determine residual HEPES in [⁶⁸Ga]Ga-radiopharmaceuticals: development and validation. Molecules. 2022;27(14):4477. DOI
• Pérez-Robles R, Salmerón-García A, Clemente-Bautista S, Jiménez-Lozano I, Cabañas-Poy MJ, Cabeza J, Navas N. Method for identification and quantification of intact teduglutide peptide using (RP)UHPLC-UV-(HESI/ORBITRAP)MS. Anal Methods. 2022;14(43):4359–4369. DOI
• Pawar R, Tivari S, Panchani D, Makasana J. A stability-indicating method development and validation for the determination of related substances in novel synthetic decapeptide by HPLC. J Pept Sci. 2024;30(10):e3610. DOI

Journal citations retrieved via PubMed. The guideline text is quoted from the adopted ICH Q2(R2) document.

This article describes analytical methodology only. It contains no usage instructions, no dosing information and no protocols of any kind.

For laboratory and in-vitro research use only. Not for human or veterinary use.